Bengaluru-based biopharmaceutical major Biocon reported a consolidated net profit of Rs 143.8 crore for the third quarter of 2025–26 (Q3FY26), a rise from a low base of Rs 25.1 crore in the same ...

Highmark recently shared how it increased generic and biosimilar access to members, focusing on drugs for multiple sclerosis, cancer and autoimmune conditions. The insurer has been working with ...

Chlorpyrifos has undergone dramatic changes in its market trajectory, from a blockbuster proprietary molecule to a globally traded generic active ingredient. AgriBusiness Global spoke with Ram ...

🚀 A comprehensive Java fundamentals guide designed to prepare backend developers for Spring Framework mastery. 12 focused modules covering OOP, collections, concurrency, design patterns, and more - ...

FRANKFURT (Reuters) -Novartis' blockbuster heart treatment Entresto saw sales growth stall in the third quarter of the year, dragging the Swiss company's shares lower, as its top-selling drug comes ...

Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...

This annual observance highlights the importance of generic medicines in providing affordable, effective and accessible healthcare to Filipinos. It was held under the theme “Ginhawang Generics, Ramdam ...